[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL423135A1 - Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation - Google Patents

Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation

Info

Publication number
PL423135A1
PL423135A1 PL423135A PL42313517A PL423135A1 PL 423135 A1 PL423135 A1 PL 423135A1 PL 423135 A PL423135 A PL 423135A PL 42313517 A PL42313517 A PL 42313517A PL 423135 A1 PL423135 A1 PL 423135A1
Authority
PL
Poland
Prior art keywords
liposome preparation
producing
pharmaceutical composition
active substance
vitamin
Prior art date
Application number
PL423135A
Other languages
Polish (pl)
Inventor
Robert Maciej Szymański
Piotr Ślifirski
Original Assignee
Axxon Spolka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axxon Spolka Z Ograniczona Odpowiedzialnoscia filed Critical Axxon Spolka Z Ograniczona Odpowiedzialnoscia
Priority to PL423135A priority Critical patent/PL423135A1/en
Publication of PL423135A1 publication Critical patent/PL423135A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem wynalazku jest preparat liposomowy zawierający jako substancję aktywną, witaminę B12, zamkniętą w pęcherzykach liposomowych, zawierająca go kompozycja farmaceutyczna oraz sposób wytwarzania preparatu liposomowego.The subject of the invention is a liposome preparation containing, as an active substance, vitamin B12, encapsulated in liposome vesicles, a pharmaceutical composition containing it, and a method for producing a liposome preparation.

PL423135A 2017-10-11 2017-10-11 Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation PL423135A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL423135A PL423135A1 (en) 2017-10-11 2017-10-11 Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL423135A PL423135A1 (en) 2017-10-11 2017-10-11 Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation

Publications (1)

Publication Number Publication Date
PL423135A1 true PL423135A1 (en) 2019-04-23

Family

ID=66167844

Family Applications (1)

Application Number Title Priority Date Filing Date
PL423135A PL423135A1 (en) 2017-10-11 2017-10-11 Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation

Country Status (1)

Country Link
PL (1) PL423135A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066889A1 (en) * 2005-12-09 2007-06-14 Korea Research Institute Of Chemical Technology Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
WO2013015634A2 (en) * 2011-07-26 2013-01-31 Hanall Biopharma Co., Ltd. Pharmaceutical composition for treating atopic dermatitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007066889A1 (en) * 2005-12-09 2007-06-14 Korea Research Institute Of Chemical Technology Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
WO2013015634A2 (en) * 2011-07-26 2013-01-31 Hanall Biopharma Co., Ltd. Pharmaceutical composition for treating atopic dermatitis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
E. LEE, THE INFLUENCE OF ALKANE CHAIN LENGTH ON THE SKIN IRRITATION PO­TENTIAL OF 1,2-ALKANEDIOLS, 2011 *
JUNG, S. H., TOPICAL APPLICATION OF LIPOSOMAL COBALAMIN HYDROGEL FOR ATOPIC DERMATITIS THERAPY, June 2011 (2011-06-01) *

Similar Documents

Publication Publication Date Title
PH12019501931A1 (en) Anti-pdl1 antibody formulations
BR112018012145A2 (en) pro-flavor delivery particles
MX2017010400A (en) Stable liquid formulation for monoclonal antibodies.
BR112017011215A2 (en) pro-flavoring distribution particles
MX2017004896A (en) Use of hexadeca-8,15-dienal as aroma chemical.
EP3808367A3 (en) Targeting aneurysm disease by modulating phagocytosis pathways
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
CL2015001772A1 (en) Pharmaceutical composition for the treatment of headache, and method of preparing it.
MX2018016362A (en) Anti-cd19 antibody formulations.
CL2016002560A1 (en) Oral solid pharmaceutical dosage form comprising siponimod, a moisture protective agent and optionally a pharmaceutical excipient; Preparation procedure
EA201790787A1 (en) REDUCTION OF VISCOSITY OF PHARMACEUTICAL COMPOSITIONS
MA40627A (en) Stable formulations of lipids and liposomes
SA519400913B1 (en) Topical formulation for promoting wound healing
UY36761A (en) SOLID ORAL FORMULATION CONTAINING IRINOTECAN AND METHOD 20 OF PREPARING THE SAME
MX2017009289A (en) Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same.
CO2017007316A2 (en) Pharmaceutical formulation
MX2018000140A (en) Formulations for improving the efficacy of hydrophobic drugs.
PL423135A1 (en) Liposome preparation that contains vitamin B12 as the active substance, pharmaceutical composition that contains it and method for producing the liposome preparation
BR112017012938A2 (en) oral use of a composition and method to enhance the appearance of cellulite
CL2016001008A1 (en) Injection formulations based on sesame oil.
GR20150100035A (en) Pharmaceutical aprepitant-containing formulation and preparation method thereof
BR112016024916A2 (en) "compound and pharmaceutical composition"
EA202091403A1 (en) 2-OXO-1-PYRROLIDINYLIMIDAZOTHIAZOLE DERIVATIVES
EA201891848A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF FIBROSIS
CY1123966T1 (en) PROCESS FOR THE PREPARATION OF ENHANCED STABILITY EPOPROSTENOL SODIUM